Appili Therapeutics Inc.
APLIF
$0.01
$0.00-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.70K | 155.20K | 250.30K | 824.90K | 854.50K |
| Total Receivables | 1.29M | 130.70K | 144.70K | 377.80K | 1.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 86.60K | 104.80K | 137.80K | 179.20K | 79.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.41M | 390.60K | 532.90K | 1.38M | 2.10M |
|
|
|||||
| Total Current Assets | 1.41M | 390.60K | 532.90K | 1.38M | 2.10M |
| Net Property, Plant & Equipment | 7.90K | 9.00K | 8.70K | 11.30K | 13.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.42M | 399.60K | 541.60K | 1.39M | 2.11M |
|
|
|||||
| Total Accounts Payable | 4.33M | 3.18M | 2.90M | 2.97M | 2.80M |
| Total Accrued Expenses | 198.90K | 64.70K | 63.70K | 77.20K | 61.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.81M | 8.55M | 8.34M | 8.54M | 8.04M |
| Total Finance Division Other Current Liabilities | 46.50K | 18.50K | 10.90K | 11.40K | 20.50K |
| Total Other Current Liabilities | 46.50K | 18.50K | 10.90K | 11.40K | 20.50K |
| Total Current Liabilities | 13.38M | 11.81M | 11.31M | 11.60M | 10.92M |
|
|
|||||
| Total Current Liabilities | 13.38M | 11.81M | 11.31M | 11.60M | 10.92M |
| Long-Term Debt | 482.30K | 537.40K | 437.20K | 515.60K | 512.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.86M | 12.35M | 11.75M | 12.12M | 11.43M |
|
|
|||||
| Common Stock & APIC | 41.64M | 42.23M | 41.49M | 41.91M | 39.75M |
| Retained Earnings | -54.55M | -54.63M | -53.10M | -53.50M | -49.90M |
| Treasury Stock & Other | 468.10K | 454.00K | 405.20K | 864.50K | 820.30K |
| Total Common Equity | -12.45M | -11.95M | -11.20M | -10.73M | -9.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.45M | -11.95M | -11.20M | -10.73M | -9.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.45M | -11.95M | -11.20M | -10.73M | -9.32M |
|
|
|||||